|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-1.06/--
|
Enterprise Value
482.07M
|
Balance Sheet |
Book Value Per Share
3.56
|
Cash Flow |
Cash Flow Yield
0.12
|
Income Statement |
Total Revenue
448.27M
|
Operating Revenue Per Share
3.23
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/15 23:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. |